Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 3.50 is 159% above its 5-year average of 1.35, near the low end of its 5-year range (0.04–16.05).
As of the fiscal period ended Tuesday, June 30, 2026. 75.12% above its 12-month average of 2.00.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.50.
QUICK RATIO (ACID-TEST)
3.50
QUICK RATIO (ACID-TEST) AVG TTM
2.00
QUICK RATIO (ACID-TEST) AVG 3Y
1.47
QUICK RATIO (ACID-TEST) AVG 5Y
1.35
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+75.12%
CURRENT VS 3Y AVG
+138.81%
CURRENT VS 5Y AVG
+158.79%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+4.48%
vs the sector median at left
Cingulate Inc.
Market Cap
$66.13M
Quick Ratio (Acid-Test)
3.50
TTM Avg
2.00
3Y Avg
1.47
5Y Avg
1.35
Market Cap
$66.01M
Quick Ratio (Acid-Test)
33.15
TTM Avg
13.79
3Y Avg
28.68
5Y Avg
44.67
Market Cap
$69.05M
Quick Ratio (Acid-Test)
1.03
TTM Avg
0.95
3Y Avg
0.86
5Y Avg
0.95
Market Cap
$65.17M
Quick Ratio (Acid-Test)
0.53
TTM Avg
4.76
3Y Avg
5.20
5Y Avg
7.10
Market Cap
$68.60M
Quick Ratio (Acid-Test)
3.83
TTM Avg
1.68
3Y Avg
1.58
5Y Avg
2.46
Market Cap
$68.68M
Quick Ratio (Acid-Test)
6.12
TTM Avg
4.89
3Y Avg
4.64
5Y Avg
6.12
Market Cap
$68.72M
Quick Ratio (Acid-Test)
0.76
TTM Avg
0.89
3Y Avg
1.63
5Y Avg
3.63
Market Cap
$63.56M
Quick Ratio (Acid-Test)
0.27
TTM Avg
0.22
3Y Avg
0.21
5Y Avg
0.99
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cingulate Inc. (CING) | $66.13M | 3.50 | 2.00 | 1.47 | 1.35 |
| iBio, Inc. (IBIO)vs › | $66.24M | 7.85 | 4.72 | 3.68 | 5.30 |
| XBiotech Inc. (XBIT)vs › | $66.01M | 33.15 | 13.79 | 28.68 | 44.67 |
| Champions Oncology, Inc. (CSBR)vs › | $69.05M | 1.03 | 0.95 | 0.86 | 0.95 |
| Gossamer Bio, Inc. (GOSS)vs › | $65.17M | 0.53 | 4.76 | 5.20 | 7.10 |
| Fortress Biotech, Inc. (FBIO)vs › | $68.60M | 3.83 | 1.68 | 1.58 | 2.46 |
| Spero Therapeutics, Inc. (SPRO)vs › | $68.68M | 6.12 | 4.89 | 4.64 | 6.12 |
| Tiziana Life Sciences Ltd (TLSA)vs › | $68.72M | 0.76 | 0.89 | 1.63 | 3.63 |
| Alps Group Inc (ALPS)vs › | $63.56M | 0.27 | 0.22 | 0.21 | 0.99 |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.16M | 9.90 | 11.46 | 13.71 | 15.39 |
Quick Ratio
3.50
Excludes inventory
Current Ratio
3.50
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 3.50 |
| 2026-03-31 | 2.55 |
| 2025-12-31 | 1.16 |
| 2025-09-30 | 1.26 |
| 2025-06-30 | 1.52 |
| 2025-03-31 | 1.87 |
| 2024-12-31 | 2.55 |
| 2024-09-30 | 7.35 |
| 2024-06-30 | 1.23 |
| 2024-03-31 | 1.21 |
| 2023-12-31 | 0.04 |
| 2023-09-30 | 0.51 |
| 2023-06-30 | 0.19 |
| 2023-03-31 | 0.56 |
| 2022-12-31 | 1.11 |
| 2022-09-30 | 1.85 |
| 2022-06-30 | 10.94 |
| 2022-03-31 | 8.94 |
| 2021-12-31 | 16.05 |
| 2021-09-30 | 1.10 |
| 2021-06-30 | 0.79 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.53 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
